The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas.

Adv Hematol · 2012 · PMC3124126 · PMID 21822434

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study demonstrated that administration of 175/75 mg temsirolimus improved ORR and PFS significantly and showed a trend toward longer overall survival (OS) [ 96 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.